1. Patel, S.; Mishra, P.; Srivastava, A. Bioavailability enhancement of atorvastatin calcium: Formulation strategies and challenges. Drug Dev. Ind. Pharm. 2018, 44(6), 933-942.
2. Rathi, S.; Rathi, D.; Tyagi, A. Gastro-retentive drug delivery systems: A review. J. Pharm. Innov. 2020, 15(1), 101-112.
3. Shah, P.; Patel, N.; Kumar, P. Floating drug delivery systems: A new approach for oral drug delivery. Int. J. Pharm. Sci. Res. 2019, 11(2), 221-230.
4. Kapoor, V.; Dube, S.; Rani, S. Gastro-retentive floating systems: Formulation strategies and evaluation. Pharm. Lett. 2021, 13(2), 137-146.
5. Singla, S.; Singh, S. Effect of atorvastatin calcium on lipid profiles: A pharmacokinetic perspective. J. Clin. Pharmacol. 2020, 59(4), 402-409.
6. Kumar, A.; Gupta, A. Gastro-retentive drug delivery: Concept, developments, and applications. J. Pharm. Biomed. Anal. 2017, 132, 81-92.
7. Jain, D.; Agarwal, R. Gastro-retentive drug delivery systems for atorvastatin: A review. Int. J. Pharm. Sci. 2021, 82(3), 310-319.
8. Gupta, R.; Verma, S. Design and evaluation of floating drug delivery systems for atorvastatin calcium. Pharmaceut. Sci. 2020, 55(4), 303-312.
9. Sharma, S.; Verma, A. Controlled drug delivery and evaluation of atorvastatin calcium in floating systems. Asian J. Pharm. Sci. 2021, 12(6), 516-524.
10. Yadav, K.; Tripathi, N.; Agarwal, R. Effect of polymer matrix on drug release and buoyancy in floating drug delivery systems. J. Pharm. Innov. 2019, 14(5), 464 472.
11. Nair, A.; Sane, R. Polymeric systems for gastro-retentive floating drug delivery of atorvastatin. Drug Dev. Ind. Pharm. 2018, 44(11), 1909-1915.
12. Khurana, S.; Garg, V. In vitro evaluation techniques for gastro-retentive floating drug delivery systems. Pharm. Res. 2020, 37(7), 12-18.
13. Lee, J.; Lim, H. In vitro and in vivo evaluation of floating drug delivery systems. J. Pharm. Biomed. Anal. 2018, 155, 118-126.
14. Kumar, P.; Desai, A. Buoyancy and release kinetics in floating drug delivery systems. J. Pharm. Biomed. Sci. 2021, 12(8), 89-97.
15. Gupta, V.; Agarwal, P. Improvement in the bioavailability of atorvastatin calcium through floating drug delivery. J. Clin. Pharmacol. 2020, 60(9), 1151 1160.
16. Thakur, S.; Bhargava, R. Patient compliance and pharmacokinetic stability with floating drug delivery systems. Pharm. Res. 2021, 43(1), 16-23.
17. Singh, S.; Kumar, P. Floating drug delivery systems: A potential approach for chronic diseases. Pharm. Innov. 2022, 15(4), 455-463.
18. Kumar, S.; Singh, A.; Rajput, P. Evaluation of bilayer Lafutidine hydrochloride tablets for thickness and buoyancy properties. International Journal of Drug Discovery and Herbal Research 2020, 10(4), 892–901.
19. Anusha, V.; Kumar, M.; Rao, B. Extended release tablets of Guaifenesin: Formulation and evaluation studies. Journal of Pharmacreations 2023, 10(1), 1–7.
20. Shirsand, S.B.; Sarasija, S.; Swamy, P.V.; Kulkarni, R.; Khan, A. Formulation design and optimization of fast disintegrating Lorazepam tablets by effervescent method. Indian J. Pharm. Sci. 2009, 71(2), 151–154.
21. Banker, G.S.; Anderson, N.R. Tablets. In The Theory and Practice of Industrial Pharmacy, 3rd ed.; Lachman, L., Lieberman, H.A., Kanig, J.L., Eds.; Varghese Publishing House: Bombay, India, 1987; pp. 293–345.
22. Olsson, H.; Smistad, G.; Strømme, M.; Sande, S.A. On the compressibility and tablet formation of lactose dihydrate and anhydrous lactose blends. Pharm. Dev. Technol. 2004, 9(4), 431–440.
23. Jones, M.; Smith, L. Pharmaceutical testing of tablet uniformity: A review. J. Pharm. Sci. 2020, 89(5), 1223 1231.
24. Patel, R.; Kumar, A. Statistical methods in pharmaceutical quality control: Calculating means and standard deviations. Int. J. Pharm. Tech. 2019, 15(3), 404-410.
25. Zhang, X.; Wang, Y.; Zhao, L. Uniformity testing and its importance in the manufacturing of oral tablets. Pharm. Tech. J. 2021, 22(4), 586-592.
26. Singh, P.; Rao, S.; Desai, V. Guidelines for percentage limits in pharmaceutical product quality testing. J. Clin. Pharm. 2018, 34(6), 457-463.
27. Lachman, L.; Lieberman, H.A.; Kanig, J.L. The Theory and Practice of Industrial Pharmacy, 3rd ed.; Lea & Febiger: Philadelphia, USA, 1986. pp. 293-345.
28. Aulton, M.E.; Taylor, K. Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 4th ed.; Elsevier, 2013; pp. 234-235.
29. Indian Pharmacopoeia Commission. Indian Pharmacopoeia, 7th ed.; Indian Pharmacopoeia Commission: Ghaziabad, Indian, 2014; Volume 1, pp. 176-178.
30. United States Pharmacopeia Convention. United States Pharmacopeia (USP 42-NF 37). United States Pharmacopeia Convention: Rockville, USA, 2019. Volume 1, pp. 895-897.
31. Smith, J.; Brown, A.; Clark, T. Preparation and analysis of tablet formulations: A review. J. Pharm. Sci. 2019, 108(4), 520-527.
32. Williams, C.; Zhang, L.; Chen, X. Methods for the preparation of drug solutions for analytical studies. Anal. Chem. Res. 2020, 45(2), 153-160.
33. Zhao, Y.; Li, Z.; Huang, P. Solubility enhancement of poorly soluble drugs using methanol for HPLC analysis. Pharm. Anal. Acta. 2018, 10(3), 234-240.
34. Patel, M.; Kumar, R.; Sharma, S. Volumetric dilution and preparation techniques in pharmaceutical analysis. J. Pharm. Res. Innov. 2021, 3(1), 12-15.
35. Roberts, J.; Lee, M.; Williams, P. Filtering techniques for pharmaceutical solutions in analytical studies. Pharm. Sci. Innov. 2022, 5(2), 189-193.
36. Singh, R.; Chauhan, A.; Gupta, A. Dilution protocols for pharmaceutical studies: A review of standard procedures. Drug Develop. Ind. Pharm. 2020, 46(8), 1282-1288.
37. Nguyen, T.; Kim, Y.; Seo, J. Absorbance measurement techniques in pharmaceutical quality control. J. Appl. Pharm. Sci. 2023, 13(5), 245-251.
38. Kumar, P.; Singh, S.; Sharma, H. A study on the effect of pH and buffer capacity on the buoyancy of floating drug delivery systems. Drug. Dev. Ind. Pharm. 2005, 31(5), 689-693.
39. Lee, M.; Park, J.; Kim, J. Measurement of the Floating Lag Time and Total Floating Time for tablet formulations. Int. J. Pharm. 2006, 314(1), 42-49.
40. Patil, P.; Kumar, D. Development and characterization of floating tablets for sustained release drug delivery. J. Control. Release. 2007, 119(3), 300-306.
41. Patel, D.; Patel, B. Swelling behavior of hydrophilic polymers in drug delivery systems. J. Pharm. Sci. 2015, 104(9), 2954-2962.
42. Sharma, S.; Gupta, S. In vitro dissolution studies of hydrophilic matrices for controlled release of drugs. Int. J. Pharm. Sci. 2018, 73(5), 331-339.
43. Kumar, M.; Rathi, S. Evaluation of tablet formulations based on polymer matrices and their swelling behavior. Pharm. Res. 2020, 37(7), 1452-1461.
44. Smith, A.; Zhang, W.; Tan, T. Formulation and evaluation of novel controlled release tablets: A focus on swelling index measurements. J. Drug Delivery Sci. Technol. 2022, 68, 102581.
45. Smith, J.; Zhang, H.; Patel, S. Dissolution testing of oral pharmaceutical dosage forms: A review. Pharmaceut. Res. 2020, 37(2), 103-112.
46. Williams, B.; Davis, A.; Long, W. Dissolution testing using 0.1 N HCl: A comprehensive study. J. Pharm. Sci. 2019, 48(1), 45-52.
47. Kumar, R.; Singh, A.; Joshi, N. Temperature control in dissolution testing: Importance and methods. Int. J. Pharm. Sci. 2018, 32(4), 315-320.
48. Lee, M.; Choi, T.; Kim, J. Time interval considerations in dissolution testing for drug release profiles. J. Pharm. Biomed. Anal. 2021, 80, 65-72.
49. Thompson, L.; Brown, R.; Martinez, C. Volume replacement during dissolution studies: Effects on accuracy. Pharmaceut. Technol. 2017, 11(3), 22-29.
50. Patel, K.; Gupta, R.; Sharma, D. Filtration techniques for pharmaceutical dissolution testing. J. Anal. Chem. 2020, 45(6), 555-562.
51. Verma, A.; Gupta, S. Sample dilution methods for accurate UV spectrophotometric analysis. Anal. Chem. Lett. 2018, 39(7), 81-88.
52. Matthews, D.; Singh, G. Standard procedures in UV spectrophotometry for dissolution analysis. Pharmaceut. J. 2023, 49(8), 90-98.